1-3 of 3
Michael A. Gordon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer

Michael A. Gordon, Nicholas C. D'Amato, Haihua Gu, Beatrice Babbs, Julia Wulfkuhle, Emanuel F. Petricoin, Isela Gallagher, Ting Dong, Kathleen Torkko, Bolin Liu, Anthony Elias, Jennifer K. Richer
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (7): 1389–1400.
https://doi.org/10.1158/1535-7163.MCT-17-0111
Published: 04 July 2017
View article titled, Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
Open the PDF for Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo

Valerie N. Barton, Nicholas C. D'Amato, Michael A. Gordon, Hanne T. Lind, Nicole S. Spoelstra, Beatrice L. Babbs, Richard E. Heinz, Anthony Elias, Paul Jedlicka, Britta M. Jacobsen, Jennifer K. Richer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (3): 769–778.
https://doi.org/10.1158/1535-7163.MCT-14-0926
Published: 09 March 2015
View article titled, Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide <em>In Vivo</em>
Open the PDF for Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer

Wendy L. Allen, Leanne Stevenson, Vicky M. Coyle, Puthen V. Jithesh, Irina Proutski, Gail Carson, Michael A. Gordon, Heinz-Josef D. Lenz, Sandra Van Schaeybroeck, Daniel B. Longley, Patrick G. Johnston
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (1): 119–131.
https://doi.org/10.1158/1535-7163.MCT-11-0510
Published: 09 January 2012
View article titled, A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer
Open the PDF for A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer in another window
Includes: Supplementary data